Holen Sie sich die Stockscreener-App
79.11
0.32%
0.25
Vorhandelsmarkt:
79.62
0.51
+0.64%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CTVA?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$78.86
Offen:
$78.41
24-Stunden-Volumen:
4.10M
Relative Volume:
1.03
Marktkapitalisierung:
$52.91B
Einnahmen:
$17.89B
Nettoeinkommen (Verlust:
$1.26B
KGV:
46.46
EPS:
1.7029
Netto-Cashflow:
$2.05B
1W Leistung:
+2.91%
1M Leistung:
-0.57%
6M Leistung:
+17.81%
1J Leistung:
+6.27%
1-Tages-Spanne:
$77.98
$80.28
1-Wochen-Bereich:
$76.52
$80.28
52-Wochen-Spanne:
$60.53
$85.63
Corteva Inc Stock (CTVA) Company Profile
Firmenname
Corteva Inc
Sektor
Branche
Telefon
(833) 267-8382
Adresse
9330 ZIONSVILLE ROAD, INDIANAPOLIS, DE
Compare CTVA vs NTR, CF, MOS, ICL
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CTVA
Corteva Inc
|
79.11 | 52.91B | 17.89B | 1.26B | 2.05B | 1.7029 |
NTR
Nutrien Ltd
|
61.54 | 29.54B | 27.83B | 2.42B | 2.21B | 4.9113 |
CF
Cf Industries Holdings Inc
|
102.17 | 15.70B | 7.41B | 2.12B | 1.62B | 11.13 |
MOS
Mosaic Company
|
21.25 | 6.75B | 12.05B | 575.40M | -534.60M | 1.6871 |
ICL
Icl Group Ltd
|
5.00 | 6.45B | 7.41B | 314.00M | 220.88M | 0.202 |
Corteva Inc Stock (CTVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-09 | Herabstufung | UBS | Buy → Neutral |
| 2026-02-05 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-10-03 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-10-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-10-02 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-08-13 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-03-31 | Hochstufung | Argus | Hold → Buy |
| 2025-03-13 | Eingeleitet | Goldman | Buy |
| 2024-10-23 | Eingeleitet | Citigroup | Buy |
| 2024-10-16 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-08-07 | Herabstufung | Argus | Buy → Hold |
| 2024-04-12 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-03-01 | Eingeleitet | Wolfe Research | Outperform |
| 2024-02-12 | Hochstufung | Loop Capital | Hold → Buy |
| 2024-02-02 | Hochstufung | Exane BNP Paribas | Underperform → Neutral |
| 2023-11-27 | Herabstufung | Berenberg | Buy → Hold |
| 2023-11-14 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2023-10-20 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2023-09-05 | Hochstufung | UBS | Neutral → Buy |
| 2023-07-25 | Herabstufung | Redburn | Buy → Neutral |
| 2023-06-28 | Eingeleitet | Canaccord Genuity | Buy |
| 2023-05-22 | Hochstufung | Vertical Research | Hold → Buy |
| 2023-04-06 | Eingeleitet | Oppenheimer | Perform |
| 2023-01-19 | Eingeleitet | Wells Fargo | Overweight |
| 2023-01-11 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-11-16 | Herabstufung | UBS | Buy → Neutral |
| 2022-11-15 | Herabstufung | Loop Capital | Buy → Hold |
| 2022-08-08 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2022-08-08 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2022-07-14 | Eingeleitet | Credit Suisse | Outperform |
| 2022-06-01 | Eingeleitet | Barclays | Overweight |
| 2022-05-06 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-04-14 | Hochstufung | Loop Capital | Hold → Buy |
| 2022-04-14 | Herabstufung | Vertical Research | Buy → Hold |
| 2022-01-31 | Hochstufung | Redburn | Neutral → Buy |
| 2021-10-18 | Herabstufung | Loop Capital | Buy → Hold |
| 2021-10-13 | Eingeleitet | Mizuho | Buy |
| 2021-10-08 | Eingeleitet | ROTH Capital | Buy |
| 2021-09-01 | Eingeleitet | Berenberg | Buy |
| 2021-08-09 | Hochstufung | Monness Crespi & Hardt | Sell → Neutral |
| 2021-05-10 | Herabstufung | BofA Securities | Buy → Underperform |
| 2021-04-19 | Hochstufung | Loop Capital | Hold → Buy |
| 2021-02-05 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-02-05 | Bestätigt | Monness Crespi & Hardt | Sell |
| 2020-12-18 | Herabstufung | Susquehanna | Positive → Neutral |
| 2020-12-14 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-11-10 | Hochstufung | Argus | Hold → Buy |
| 2020-10-19 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-10-19 | Herabstufung | Exane BNP Paribas | Outperform → Underperform |
| 2020-08-11 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-08-10 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-07-13 | Hochstufung | BofA Securities | Underperform → Buy |
| 2020-06-26 | Eingeleitet | Cleveland Research | Neutral |
| 2020-06-16 | Hochstufung | Vertical Research | Hold → Buy |
| 2020-06-08 | Herabstufung | Monness Crespi & Hardt | Neutral → Sell |
| 2020-05-11 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2020-04-17 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2020-04-17 | Hochstufung | Loop Capital | Sell → Hold |
| 2020-04-01 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2020-03-31 | Hochstufung | Susquehanna | Neutral → Positive |
| 2020-03-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-03-19 | Hochstufung | Edward Jones | Hold → Buy |
| 2020-03-13 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-03-10 | Hochstufung | Monness Crespi & Hardt | Sell → Neutral |
Alle ansehen
Corteva Inc Aktie (CTVA) Neueste Nachrichten
Exclusive | Corteva, a $50 Billion Seed-and-Pesticide Maker, Is Exploring a Breakup - WSJ
Is Mission Produce Winning Through Operational Efficiency Gains? - TradingView
Hsbc Holdings PLC Cuts Position in Corteva, Inc. $CTVA - MarketBeat
FMC and Corteva partner to expand access to Rimisoxafen technology - MSN
Corteva (CTVA) Stock Could Be 13% Undervalued After FMC Herbicide Deal - Sahm
Will FMC's (FMC) Rimisoxafen Deal With Corteva Reshape Its Cash Flow Repair Narrative? - simplywall.st
Why Corteva’s Lumialza seed treatment is drawing fresh attention from corn growers - AD HOC NEWS
What Corteva (CTVA)'s Rimisoxafen Deal With FMC Means For Shareholders - Sahm
US' FMC, Corteva partner to expand rimisoxafen weed control - Fibre2Fashion
How MustGrow Biologics Benefits from Agrochemical Realignment with Patented Bioactive Technology – Pressure on Bayer and Corteva - news.financial
Corteva Inc. stock outperforms competitors on strong trading day - MarketWatch
FMC and Corteva Partner to Expand Access to Rimisoxafen Technology - Yahoo Finance
Corteva Inc (CTVA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Corteva Inc (CTVA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Corteva Inc (CTVA) Institutional Confidence - TradingKey
Corteva Inc (CTVA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Corteva Inc (CTVA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Corteva stock ticks up to $77.45 as CortevaUS promotes photo contest for branded T-shirts - Traders Union
Corteva Inc (CTVA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Corteva Inc (CTVA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Corteva Inc (CTVA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CTVA: EU gene editing approval and tech advances drive growth, efficiency, and new crop opportunities - TradingView
FMC and Corteva Sign Strategic Supply and License Agreement for Rimisoxafen Herbicide Technology - iGrow News
FMC Corporation and Corteva Expand Access to Breakthrough Rimiso - GuruFocus
FMC Corp. (FMC) Partners with Corteva to Enhance Herbicide Techn - GuruFocus
FMC, Corteva announce co-exclusive rimisoxafen supply and license pact - TipRanks
FMC, Corteva to partner on herbicide technology supply and license deal (FMC:NYSE) - Seeking Alpha
FMC and Corteva partner on herbicide technology distribution - Investing.com
FMC and Corteva partner on herbicide technology distribution By Investing.com - Investing.com South Africa
Fmc Corporation And Corteva Expand Access To Breakthrough Rimisoxafen Herbicide Technology - TradingView
FMC Corporation and Corteva Expand Access to Breakthrough Rimisoxafen Herbicide Technology - Financial Times
FMC & Corteva Unite: A New Front in the War on Herbicide-Resistant Weeds - BriefGlance
Corteva agrees to $85 million settlement - The Fence Post
Communities for a Better Environment v. Corteva Inc. et al. - NRDC
Entropy Technologies LP Has $2.28 Million Position in Corteva, Inc. $CTVA - MarketBeat
FMC and Corteva partner to expand access to innovative herbicide rimisoxafen in Americas - Pluang
Cortea raises €12M to help audit firms adopt AI without compromising audit quality - GlobeNewswire Inc.
Corteva Says No To FTC Trial Date In Pesticides Case - Law360
Can Higher Avocado Pricing Sustain Mission Produce's Growth? - TradingView
Corteva Inc Stock (US22052L1044): Analyst targets and valuation keep the shares in focus - AD HOC NEWS
Corteva (CTVA) Stock Valuation As Industry Commentary Highlights Growth Efforts And Ongoing Headwinds - Yahoo Finance
The Technical Signals Behind (CTVA) That Institutions Follow - Stock Traders Daily
Adams Natural Resources Fund Inc. Reduces Position in Corteva, Inc. $CTVA - MarketBeat
Corteva, Inc. Files Amended 8-K/A with SEC Detailing Company Information and Addresses - Minichart
Corteva (CTVA) Faces Increased Restructuring Costs and Legal Set - GuruFocus
Corteva (CTVA): New Buy Recommendation for This Basic Materials Giant - The Globe and Mail
Corteva (CTVA) Enhances Efficiency with Multi-Year Restructuring Plan - GuruFocus
Corteva flags higher restructuring charges, plans Spain site exit - Reuters
Corteva says setting trial date in US FTC case now would be 'premature' - MLex
Corteva sees higher restructuring charges, plans to cease production at Spanish site (CTVA:NYSE) - Seeking Alpha
Corteva Management Recently Committed To Next Phase Of Plan To Include Intended Cessation Of Co's Production Activities At Site In Asturias, Spain - TradingView
Finanzdaten der Corteva Inc-Aktie (CTVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.14%
1.24%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):